Furthermore, in mouse models of NAFLD, dysregulation of lipid metabolism causes a selective intrahepatic CD4+ but not CD8+ T lymphocyte loss and further accelerates hepatocarcinogenesis, which is consistent to that of human samples (37). Here, CD4 is linked to metabolic dysfunction-associated steatotic liver disease.